Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
- ViiV Healthcare shares data from landmark 2-drug regimen trials at AIDS 2018
- US FDA Advisory Committee endorses the effectiveness and safety of single-dose tafenoquine for the radical cure of P. vivax malaria
Tweets from GSK
-
GSK @GSK
#NEWS: Thanks to #FDA approval, @GSK and @MMV will offer the first new medicine in over 60 years for relapsing #malaria. gsk.to/2LpFaKh
about 4 hours ago
-
GSK @GSK
#HIV is a key area of research for us, through our dedicated global leading HIV company, @ViiVHC. See how our scientists are working to find a cure: gsk.to/2H84HSb #BehindTheScience
about 11 hours ago
-
GSK @GSK
“#Artificialintelligence will broadly impact discovery research in the pharmaceutical industry – we’ll be more data driven and there’ll be less unconscious bias in our decision-making.” – Chris Larminie #HealthQuake @TheCrick
about 17 hours ago
